Crizotinib sensitizes the erlotinib resistant HCC827GR5 cell line by influencing lysosomal function
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Cellular Physiology"
DOI: 10.1002/jcp.29463
Abstract: In non‐small cell lung cancer, sensitizing mutations in epidermal growth factor receptor (EGFR) or cMET amplification serve as good biomarkers for targeted therapies against EGFR or cMET, respectively. Here we aimed to determine how this… read more here.
Keywords: crizotinib; cell; cell line; hcc827gr5 cell ... See more keywords